Goldman Sachs raised the firm’s price target on GE HealthCare (GEHC) to $98 from $86 and keeps a Buy rating on the shares. After a year when fundamentals diverged from stock performance, 2026 should represent a return to normalized patterns where organic growth defines relative valuation, the analyst tells investors in a research note.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- GE HealthCare price target raised to $95 from $90 at Stifel
- GE HealthCare urges shareholders to reject ‘mini-tender’ offer by Potemkin
- Midday Fly By: Nvidia launches Rubin platform, Vistra to acquire Cogentrix
- NXP Semiconductors, GE HealthCare collaborate for AI in acute care
- GE HealthCare price target raised to $95 from $92 at Evercore ISI